Cleveland Clinic Taussig Cancer Institute

Taussig Cancer Institute is the hub for Cleveland Clinic Cancer Center.

 

Cleveland Clinic Taussig Cancer Institute
J

Trastuzumab Deruxtecan in HER2+ MBC Efficacy Analysis

By Cleveland Clinic Taussig Cancer Institute FEATURING Jame Abraham
By Cleveland Clinic Taussig Cancer Institute FEATURING Jame Abraham
453 views
October 5, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

20:09
AstraZeneca Oncology

Management Strategies for Anemia in First-line Maintenance Therapy f…

Feat. D. Czel, C. Arn

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay
ASCO 2020 Highlights
09:21
Cleveland Clinic Taussig Cancer Institute

Trastuzumab Deruxtecan in HER2+ MBC Efficacy Analysis

Feat. J. Abraham
11:48
Cleveland Clinic Taussig Cancer Institute

2020 ASCO Update on Locally Advanced Rectal Cancer: Can Total Neoadj…

Feat. S. Kamath